| 151 | Alteogen Inc. | 196170.KQ | | 12.3B USD |
| 152 | CSPC Pharmaceutical Group Limited | CSPCY | | 12.2B USD |
| 153 | Olympus Corporation | 7733.T | | 12.2B USD |
| 154 | BrightSpring Health Services, Inc. Common Stock | BTSG | | 12.2B USD |
| 155 | BrightSpring Health Services, Inc. Tangible Equity Unit | BTSGU | | 12.1B USD |
| 156 | Recordati Industria Chimica e Farmaceutica S.p.A. | REC.MI | | 12.1B USD |
| 157 | Halozyme Therapeutics, Inc. | HALO | | 12B USD |
| 158 | Cipla Limited | CIPLA.NS | | 12B USD |
| 159 | Fresenius Medical Care AG | FMCQF | | 12B USD |
| 160 | Pro Medicus Limited | PME.AX | | 12B USD |
| 161 | Madrigal Pharmaceuticals, Inc. | MDGL | | 11.9B USD |
| 162 | Recordati S.p.A. | RCDTF | | 11.8B USD |
| 163 | Sino Biopharmaceutical Limited | 1177.HK | | 11.8B USD |
| 164 | CSPC Pharmaceutical Group Limited | 1093.HK | | 11.8B USD |
| 165 | DaVita Inc. | DVA | | 11.7B USD |
| 166 | Zydus Lifesciences Limited | ZYDUSLIFE.NS | | 11.6B USD |
| 167 | Summit Therapeutics Inc. | SMMT | | 11.6B USD |
| 168 | Aier Eye Hospital Group Co., Ltd. | 300015.SZ | | 11.5B USD |
| 169 | Haisco Pharmaceutical Group Co., Ltd. | 002653.SZ | | 11.5B USD |
| 170 | Lupin Limited | LUPIN.NS | | 11.5B USD |
| 171 | Globus Medical, Inc. | GMED | | 11.3B USD |
| 172 | Bio-Techne Corporation | TECH | | 11.3B USD |
| 173 | Axsome Therapeutics, Inc. | AXSM | | 11.2B USD |
| 174 | Max Healthcare Institute Ltd | MAXHEALTH.NS | | 11.1B USD |
| 175 | Mankind Pharma Limited | MANKIND.NS | | 11B USD |
| 176 | Akeso, Inc. | 9926.HK | | 10.9B USD |
| 177 | Elanco Animal Health Incorporated | ELAN | | 10.8B USD |
| 178 | The Ensign Group, Inc. | ENSG | | 10.8B USD |
| 179 | Glaukos Corporation | GKOS | | 10.7B USD |
| 180 | Financière de Tubize S.A. | TUB.BR | | 10.6B USD |
| 181 | Dr. Reddy's Laboratories Limited | DRREDDY.NS | | 10.5B USD |
| 182 | Universal Health Services, Inc. | UHS | | 10.5B USD |
| 183 | Molina Healthcare, Inc. | MOH | | 10.4B USD |
| 184 | Sichuan Kelun Pharmaceutical Co., Ltd. Class A | 002422.SZ | | 10.4B USD |
| 185 | Praxis Precision Medicines, Inc. | PRAX | | 10.2B USD |
| 186 | RemeGen Co. Ltd. Class A | 688331.SS | | 10.1B USD |
| 187 | Henry Schein, Inc. | HSIC | | 10B USD |
| 188 | Insulet Corp. | PODD | | 9.8B USD |
| 189 | Abivax S.A. | ABVX.PA | | 9.8B USD |
| 190 | WuXi XDC Cayman Inc | 2268.HK | | 9.7B USD |
| 191 | Tempus AI, Inc. | TEM | | 9.7B USD |
| 192 | Krystal Biotech, Inc. | KRYS | | 9.6B USD |
| 193 | Ionis Pharmaceuticals, Inc. | IONS | | 9.6B USD |
| 194 | bioMérieux S.A. | BIM.PA | | 9.5B USD |
| 195 | Cytokinetics, Incorporated | CYTK | | 9.5B USD |
| 196 | Protagonist Therapeutics, Inc. | PTGX | | 9.5B USD |
| 197 | Bio-Rad Laboratories, Inc. | BIO | | 9.5B USD |
| 198 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 600196.SS | | 9.4B USD |
| 199 | Bangkok Dusit Medical Services Public Company Limited | BDMS.BK | | 9.3B USD |
| 200 | Shanghai Pharmaceuticals Holding Co., Ltd | 601607.SS | | 9.3B USD |
